Cargando…

Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma

Background: Endometriosis is a benign estrogen-dependent gynecological disease involving components of the female genital tract (uterus, Fallopian tubes, ovaries, large, round, and utero-sacral ligaments) and intra- and extraperitoneal regions. Since the moment of its etiopathogeny has been identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Păvăleanu, Ioana, Lozneanu, Ludmila, Balan, Raluca Anca, Giuşcă, Simona Eliza, Avădănei, Elena-Roxana, Căruntu, Irina-Draga, Amălinei, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112801/
https://www.ncbi.nlm.nih.gov/pubmed/33817715
http://dx.doi.org/10.47162/RJME.61.3.12
_version_ 1783690739855654912
author Păvăleanu, Ioana
Lozneanu, Ludmila
Balan, Raluca Anca
Giuşcă, Simona Eliza
Avădănei, Elena-Roxana
Căruntu, Irina-Draga
Amălinei, Cornelia
author_facet Păvăleanu, Ioana
Lozneanu, Ludmila
Balan, Raluca Anca
Giuşcă, Simona Eliza
Avădănei, Elena-Roxana
Căruntu, Irina-Draga
Amălinei, Cornelia
author_sort Păvăleanu, Ioana
collection PubMed
description Background: Endometriosis is a benign estrogen-dependent gynecological disease involving components of the female genital tract (uterus, Fallopian tubes, ovaries, large, round, and utero-sacral ligaments) and intra- and extraperitoneal regions. Since the moment of its etiopathogeny has been identified, the intrinsic capacity of endometriosis malignant transformation has been hypothesized. Patients, Materials and Methods: Our study included a total number of 50 patients diagnosed with endometriosis (31 cases) and endometriosis-related ovarian carcinoma (EOC) (19 cases). A clinicopathological and immunohistochemical study directed towards the detection of atypical transition lesions and the similitudes in epithelial–mesenchymal transition (EMT) phenomenon [E-cadherin/β-catenin/cytokeratin 18 (CK18)], apoptosis [B-cell lymphoma 2 (Bcl-2)/Bcl-2-associated X (Bax)], and hormonal dynamics mirrored by the immunoexpression of estrogen receptor (ER) and progesterone receptor (PR) in endometriosis and EOC glands and stroma has been performed. Results: Our study showed a higher immunoexpression of CK18 and E-cadherin in endometriosis than in neoplastic counterparts, while β-catenin had a stronger immunoexpression in tumors compared with endometriotic areas, with statistically significant differences between the studied groups. Bcl-2/Bax higher rate in endometriosis had a statistically significant association to a more aggressive tumor behavior (p=0.020). ER immunoexpression was stronger in endometriosis, with less negative scores compared to EOC, while PR immunoexpression was stronger in endometriosis, with a lower percent of negative scores compared to EOC. PR immunostaining was correlated to ovarian location of endometriosis (p=0.004) and tumor grade of EOC (p=0.027). Stromal ER and PR immunoexpression has been significantly lower in endometriosis in comparison to tumor stroma (p=0.001) and PR stromal immunoexpression had been higher in more differentiated tumors compared to less differentiated types (p=0.005). Conclusions: Our study supports that endometriosis is a precursor of EOC by the identification and the coexistence of both lesions in the investigated cases, the identification of intermediate lesions, as well as the expression of EMT immunomarkers, along with apoptosis and steroid receptors immunoexpression.
format Online
Article
Text
id pubmed-8112801
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
record_format MEDLINE/PubMed
spelling pubmed-81128012021-06-01 Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma Păvăleanu, Ioana Lozneanu, Ludmila Balan, Raluca Anca Giuşcă, Simona Eliza Avădănei, Elena-Roxana Căruntu, Irina-Draga Amălinei, Cornelia Rom J Morphol Embryol Original Paper Background: Endometriosis is a benign estrogen-dependent gynecological disease involving components of the female genital tract (uterus, Fallopian tubes, ovaries, large, round, and utero-sacral ligaments) and intra- and extraperitoneal regions. Since the moment of its etiopathogeny has been identified, the intrinsic capacity of endometriosis malignant transformation has been hypothesized. Patients, Materials and Methods: Our study included a total number of 50 patients diagnosed with endometriosis (31 cases) and endometriosis-related ovarian carcinoma (EOC) (19 cases). A clinicopathological and immunohistochemical study directed towards the detection of atypical transition lesions and the similitudes in epithelial–mesenchymal transition (EMT) phenomenon [E-cadherin/β-catenin/cytokeratin 18 (CK18)], apoptosis [B-cell lymphoma 2 (Bcl-2)/Bcl-2-associated X (Bax)], and hormonal dynamics mirrored by the immunoexpression of estrogen receptor (ER) and progesterone receptor (PR) in endometriosis and EOC glands and stroma has been performed. Results: Our study showed a higher immunoexpression of CK18 and E-cadherin in endometriosis than in neoplastic counterparts, while β-catenin had a stronger immunoexpression in tumors compared with endometriotic areas, with statistically significant differences between the studied groups. Bcl-2/Bax higher rate in endometriosis had a statistically significant association to a more aggressive tumor behavior (p=0.020). ER immunoexpression was stronger in endometriosis, with less negative scores compared to EOC, while PR immunoexpression was stronger in endometriosis, with a lower percent of negative scores compared to EOC. PR immunostaining was correlated to ovarian location of endometriosis (p=0.004) and tumor grade of EOC (p=0.027). Stromal ER and PR immunoexpression has been significantly lower in endometriosis in comparison to tumor stroma (p=0.001) and PR stromal immunoexpression had been higher in more differentiated tumors compared to less differentiated types (p=0.005). Conclusions: Our study supports that endometriosis is a precursor of EOC by the identification and the coexistence of both lesions in the investigated cases, the identification of intermediate lesions, as well as the expression of EMT immunomarkers, along with apoptosis and steroid receptors immunoexpression. Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2020 2021-02-07 /pmc/articles/PMC8112801/ /pubmed/33817715 http://dx.doi.org/10.47162/RJME.61.3.12 Text en Copyright © 2020, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Original Paper
Păvăleanu, Ioana
Lozneanu, Ludmila
Balan, Raluca Anca
Giuşcă, Simona Eliza
Avădănei, Elena-Roxana
Căruntu, Irina-Draga
Amălinei, Cornelia
Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
title Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
title_full Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
title_fullStr Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
title_full_unstemmed Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
title_short Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
title_sort insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112801/
https://www.ncbi.nlm.nih.gov/pubmed/33817715
http://dx.doi.org/10.47162/RJME.61.3.12
work_keys_str_mv AT pavaleanuioana insightsintomolecularpathwaysofendometriosisandendometriosisrelatedovariancarcinoma
AT lozneanuludmila insightsintomolecularpathwaysofendometriosisandendometriosisrelatedovariancarcinoma
AT balanralucaanca insightsintomolecularpathwaysofendometriosisandendometriosisrelatedovariancarcinoma
AT giuscasimonaeliza insightsintomolecularpathwaysofendometriosisandendometriosisrelatedovariancarcinoma
AT avadaneielenaroxana insightsintomolecularpathwaysofendometriosisandendometriosisrelatedovariancarcinoma
AT caruntuirinadraga insightsintomolecularpathwaysofendometriosisandendometriosisrelatedovariancarcinoma
AT amalineicornelia insightsintomolecularpathwaysofendometriosisandendometriosisrelatedovariancarcinoma